We followed the hypothesis that iPS-MSCs might provide an unlimited and more standardized alternative to primary MSCs for stromal support of hematopoietic stem and progenitor cells (HPCs). To this end, we have reprogrammed bone marrow-derived MSCs into iPSCs and subsequently re-differentiated them towards iPS-MSCs as described before \[[@CR1]\]. iPS-MSCs revealed similar fibroblastoid morphology, immunophenotype, and in vitro differentiation potential as primary MSCs (Additional file [1](#MOESM1){ref-type="media"}). HPCs were isolated from cord blood after written consent (Ethic Committee of RWTH Aachen: EK187/08). CD34^+^ cells were stained with carboxyfluorescein succinimidyl ester (CFSE) to monitor cell proliferation \[[@CR2]\]. Flow cytometric analysis of residual CFSE staining after 5 days demonstrated that HPCs proliferated significantly faster if cultured with stromal support of either MSCs or iPS-MSCs (Fig. [1a](#Fig1){ref-type="fig"}). CD34 expression declined within a few cell divisions without feeder layer, whereas it was largely maintained over five subsequent cell divisions under both co-culture conditions (Fig. [1b](#Fig1){ref-type="fig"}). Overall, the expression of CD34 and CD133 declines after five cell divisions, which is consistent with previous observations \[[@CR2]\]. Statistical analysis of CD34, CD38, CD45, and CD133 expression in relation to the cell division numbers indicated that co-culture with primary MSCs was slightly advantageous as compared to iPS-MSCs for maintenance of a primitive hematopoietic immunophenotype (Fig. [1c](#Fig1){ref-type="fig"}).Fig. 1The hematopoietic supportive function of iPS-MSCs. **a** CD34^+^ cells were stained with CFSE and cultured with or without feeder cells for 5 days. Co-culture of HPCs with either MSCs or iPS-MSCs enhanced the number of cell divisions significantly (\*\**P* \< 0.01; \*\*\**P* \< 0.001; *n* = 5---each with three biological replicates for MSCs and iPS-MSCs; MFI = mean fluorescence intensity). **b** Dot plots show CD34 expression in relation to the number of cell divisions (as a reference we used additional measurements at day 0; the number of cell divisions in different CFSE-gates is indicated). **c** We gated for specific cell division numbers and analyzed the signal intensity of CD34, CD133, CD45, and CD38 as compared to culture without feeder layer (*gray*). Co-culture with MSCs (*red*) or iPS-MSCs (*blue*) led to an increase of CD34 and CD133 expression and a decrease of CD45 expression in proliferating cells (without feeder vs. MSCs: \**P* \< 0.05, \*\**P* \< 0.01; without feeder vs. iPS-MSCs: ^\#^ *P* \< 0.05, ^\#\#^ *P* \< 0.01; MSCs vs. iPS-MSCs : ^§^ *P* \< 0.05; *n* = 5---each with three biological replicates for MSCs and iPS-MSCs). **d** CFU frequency was significantly increased by co-culture with either MSCs or iPS-MSCs (\*\**P* \< 0.01, *n* = 3---each with three biological replicates for MSCs and iPS-MSCs). There was no significant bias for specific types of colonies. BFU-E = burst-forming-unit erythroid; CFU-E = colony-forming-unit erythroid; CFU-G = colony-forming-unit granulocyte; CFU-M = colony-forming-unit macrophage; CFU-GM = colony-forming-unit granulocyte, macrophage; CFU-GEMM = colony-forming-unit granulocyte, erythrocyte, macrophage, megakaryocyte. **e** Frequency of long-term culture initiating cells (LTC-IC) was significantly higher in co-culture with primary bone marrow-derived MSCs as compared to iPS-MSCs or without stromal support (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, *n* = 3---each with three biological replicates for MSCs and iPS-MSCs). Mean ± S.D. is depicted

We assessed the CFU frequency in freshly isolated HPCs or upon culture-expansion for 7 days: without stromal support, there was no expansion of CFUs, whereas CFU frequency was significantly increased under co-culture conditions with MSCs or iPS-MSCs (Fig. [1d](#Fig1){ref-type="fig"}). CFU frequency was not significantly affected if HPCs were co-cultured either with MSCs or iPS-MSCs, and there was no bias towards specific types of colonies (Fig. [1d](#Fig1){ref-type="fig"}). However, if HPCs were cultured for 5 weeks in a long-term culture-initiating cell (LTC-IC) assay \[[@CR2]\], different hematopoiesis supporting capacities of MSCs and iPS-MSCs became evident: long-term culture of HPCs gave rise to a significantly higher number of colonies on MSCs compared to iPS-MSCs (Fig. [1e](#Fig1){ref-type="fig"}).

There is evidence that besides cytokine secretion, direct cell-cell interaction between HPCs and MSCs is crucial for the hematopoiesis supportive function and migration \[[@CR3]--[@CR5]\]---and this is reflected by cellular polarization \[[@CR6], [@CR7]\]. In fact, co-culture with MSCs gave rise to a significantly higher fraction of elongated cells as compared to iPS-MSCs or feeder-free conditions (Fig. [2a](#Fig2){ref-type="fig"}). Subsequently, we reanalyzed previously published gene expression profiles of MSCs, iPSCs, and iPS-MSCs (GSE46019, GSE38806, and GSE54766) \[[@CR1]\] with focus on a set of genes that has been considered to be functionally relevant for cell-cell interaction \[[@CR8]\]. Overall, these genes were expressed at very similar levels in MSCs and iPS-MSCs, underlining the close molecular relationship of both cell preparations (Fig. [2b](#Fig2){ref-type="fig"}). Among the selected genes, only laminin β1 (*LAMB1*) was higher expressed in iPS-MSCs (limma adjusted *P* value: *P* = 0.004), and the vascular cell adhesion molecule 1 (*VCAM1*; CD106) was higher expressed in MSCs (*P* = 0.0018). This trend was also observed by flow cytometric analysis of VCAM1 (Fig. [2c](#Fig2){ref-type="fig"}), although it was only expressed in a relatively small subset of MSCs. We have previously demonstrated that *VCAM1* is higher expressed in bone marrow-derived MSCs than in adipose tissue-derived MSCs \[[@CR9]\]. Furthermore, we have shown that siRNA-mediated knockdown of *VCAM1* in MSCs entails lower proliferation rates of co-cultured HPCs \[[@CR2]\]. It has been suggested that VCAM1 positive and negative subsets of MSCs differ in their biological function \[[@CR10], [@CR11]\] and that particularly the VCAM1 positive subset has higher immunoregulatory potential \[[@CR11]\]. Lower expression of *VCAM1* in iPS-MSCs might therefore be one reason for reduced stromal support. On the other hand, N-cadherin (*CDH2*), which is also relevant for interaction of MSCs with HSCs \[[@CR5]\], was in tendency higher expressed in iPS-MSCs than MSCs. Notably, differential expression of *LAMB1*, *VCAM1*, and *CDH2* was also reflected in DNA methylation patterns of MSCs and iPS-MSCs (Additional file [2](#MOESM2){ref-type="media"}). Either way, it is likely that a combination of adhesion proteins and chemokines evokes the differences in hematopoiesis supportive potential.Fig. 2Differences in cell-cell interaction with different feeder layers. **a** The percentage of HPCs with elongated morphology was scored as described before \[[@CR6]\]. Particularly, co-culture with MSCs stimulated cellular elongation (\**P* \< 0.05, *n* = 3---each with three biological replicates for MSCs and iPS-MSCs). **b** Gene expression of relevant genes for cellular interaction with HPCs were analyzed in MSCs, iPSCs, and iPS-MSCs. Overall, all genes were expressed at very similar levels in primary MSCs and iPS-MSCs---except for Laminin β1 (*LAMB1*; higher expressed in iPS-MSCs; \*\**P* \< 0.01) and vascular cell adhesion molecule 1 (*VCAM1*; higher expressed in MSCs; \*\**P* \< 0.01). **c** Mean fluorescence intensity of VCAM1 (CD106) expression in flow cytometric analysis (three biological replicates for MSCs and iPS-MSCs). Mean ± S.D. is depicted

Taken together, our iPS-MSCs provide a less hematopoiesis supportive microenvironment than primary MSCs, particularly after long-term co-culture. This tendency was not observed in a recent study by Moslem et al. \[[@CR12]\], but these authors did not test for maintenance of LTC-ICs. It is conceivable that optimized differentiation procedures of iPSCs towards cellular components of the hematopoietic stem cell niche as well as 3D-culture systems will further enhance stromal support to ultimately facilitate in vitro expansion of HPCs.
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Additional file 1:Functional characterization of iPS-MSCs. (A) Phase contrast images of MSCs and iPS-MSCs: iPS-MSCs revealed similar fibroblastoid morphology as MSCs. (B) iPS-MSCs displayed similar immunophenotypic characteristics as primary MSCs (MFI = mean fluorescence intensity; mean ± S.D. of three biological replicates is presented; \**P* \< 0.05, \*\**P* \< 0.01). (C) MSCs and iPS-MSCs were differentiated for three weeks towards adipogenic, osteogenic, and chondrogenic lineages and subsequently stained with BODIPY/DAPI, Alizarin Red, or Alcian Blue/PAS, respectively (in analogy to our previous work \[[@CR1]\]). Controls were simultaneously cultured in normal growth medium (DMEM supplemented with 10 % human platelet lysate). Representative images are shown. (PDF 153 kb)Additional file 2:DNA methylation is in line with differential expression of *VCAM1*, *CDH2*, and *LAMB1*. DNA methylation levels of CpG dinucleotides in the genes *VCAM1*, *CDH2*, and *LAMB1* were analyzed for bone marrow-derived MSCs, iPS-MSCs, and iPSCs using the Illumina 450 k BeadChip data (GSE17448 and GSE54767) as described in detail in our previous work \[[@CR1]\]. DNA methylation level is given as β-value ranging from 0 (no methylation) to 1 (100 % methylation). Genomic location of the respective CpG sites and statistical significance of MSCs vs. iPS-MSCs are indicated (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, TSS1500 = 1500 bp upstream of transcription start site; TSS200 = 200 bp upstream of TSS; UTR = untranslated region). DNA methylation of *VCAM1* was higher in iPS-MSCs than MSCs. In contrast, close to the transcription start site of *LAMB1* and *CDH2* several CpGs revealed significantly lower DNA methylation in iPS-MSCs than primary MSCs. These epigenetic differences may therefore be relevant for the observed differences in gene expression. (PDF 362 kb)
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